← Back to catalogue
Research draft

breast cancer

vr.tr.breast-cancer · PHY.LIV

Let an agent give accurate general information on breast cancer, encourage screening and prompt assessment of changes, explain diagnosis and treatment pathways in general terms, and point to specialist care and support without individual medical advice.

Thing Registry Physical world and living systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent give accurate general information on breast cancer, encourage screening and prompt assessment of changes, explain diagnosis and treatment pathways in general terms, and point to specialist care and support without individual medical advice.

A cancer that forms in the tissues of the breast, most commonly in the ducts or lobules, affecting mainly women but also men, with types ranging from ductal carcinoma in situ to invasive and metastatic disease; it is the most common cancer in women worldwide, detected by screening and symptoms, and treated with surgery, radiotherapy, chemotherapy, hormone and targeted therapies.

What it is for: A cancer requiring screening, diagnosis, treatment and support.

It can be explain symptoms and screening; describe types and stages in general terms; explain treatment pathways and genetic risk; find specialist centres and patient organisations.

Distinguishing features

Breast tissue origin

Several subtypes by receptors

Screening-detectable

Hereditary risk in some families

What it looks like

Not physical as a concept; a diagnosis from imaging and pathology.

How it is recognised

Breast lumps, skin or nipple changes

Diagnosed by mammography, ultrasound and biopsy

Most breast lumps are benign

Related models

is a kind of - category

breast neoplasm

is a kind of - category

thoracic cancer

is treated by - services

health care

is related to - shared hereditary risk

ovarian cancer

In practice

Families and kinds

ductal carcinoma in situ

invasive ductal and lobular carcinoma

hormone receptor positive, HER2 positive and triple negative subtypes

metastatic breast cancer

male breast cancer and rare types such as phyllodes tumours

Standards and regulation

Clinical guidelines from oncology societies

National screening programmes

Genetic testing guidelines for BRCA variants

Failure modes and hazards

Delayed assessment of symptoms

Agents giving individual medical advice

Unproven treatments

Also called

metastatic cancer to the breastbreast papillary neoplasmcutaneous breast cancermetastatic breast cancerbreast malignant phyllodes tumornon-metastatic breast cancerearly-stage breast cancerinvasive ductal carcinomafemale breast cancerestrogen-receptor negative breast cancerprogesterone-receptor negative breast cancerHer2-receptor negative breast cancerbreast myoepithelial neoplasmbreast granular cell tumorbreast sarcomabreast carcinomamalignant breast melanomabreast lymphomamammary tumorbreast vascular neoplasmmalignant neoplasm of nipplesalivary gland type cancer of the breastHormone receptor positive breast tumorinflammatory breast cancermale breast cancertriple-negative breast cancerbreast mucinous carcinomabreast secretory carcinomabreast medullary carcinomaacinic cell breast carcinomainvasive tubular breast carcinomabreast scirrhous carcinomaBasal-like carcinomainvasive ductal and lobular carcinomapleomorphic breast carcinomaEhrlich tumor carcinomalipid-rich carcinomacribriform carcinomanipple carcinomabilateral breast cancer

+10

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Symptoms Changes to check.

Prompt assessment.

Changes

Breast changes.

Changes

Changes.

  1. Has the person noticed a lump, skin change, nipple discharge or other breast change? boundary
  2. Should they see a doctor promptly for assessment? action

Screening

Screening programmes.

Screening

Screening.

  1. Who is invited for screening here, at what ages and intervals? provenance
  2. What are the benefits and limitations of screening, according to health authorities? provenance
Understand The disease.

General information.

Types

Types and stages.

Types

Types.

  1. What type, subtype and stage is being discussed, in general terms? definition
  2. Is the user asking about their own diagnosis or results? boundary

Risk

Risk factors.

Risk

Risk factors.

  1. What do health authorities say about risk factors and hereditary variants? provenance
  2. Who is eligible for genetic counselling? provenance
Treatment Care pathway.

Specialist care.

Pathway

Diagnosis and treatment.

Pathway

Pathway.

  1. How is breast cancer diagnosed and treated, according to guidelines, in general terms? provenance
  2. Which questions should be asked of the oncology team? action

Trials

Clinical trials.

Trials

Trials.

  1. Which trials are recruiting, according to registries? provenance
  2. How can a patient discuss trials with their team? action
Support Living with it.

Support helps.

Organisations

Patient groups.

Organisations

Patient groups.

  1. Which patient organisations support people with breast cancer here, including men? provenance
  2. Which services do they offer? provenance

Life

After treatment.

Life

After treatment.

  1. What follow-up and survivorship support is available? provenance
  2. How can carers be supported? provenance

What the second pass must settle

  • Should each subtype be a separate entry?
  • How should screening programmes be localised?
  • How should support organisations be linked?